Jun. 7 at 5:40 PM
$LLKKF To whomever is left of the Lake Army. I've been holding a stock for 4 years that went from
$4 to
$16 and down to .50cents. Sound familiar. Well, this one is different. They've got several gene-editing products in clinical trials and close to approval(s). They just signed an agreement with SKorea for licensing one of their products to address Retinitis Pigmentosa, a disease that leads to blindness. So far, their trials are showing improvement in vision and what looks like reversal of the disease w/o any side effects. Plus, it's a one-shot solution for life. The stock is Ocugen. Symbol OCGN. Went over
$1 to
$1.06, and we may finally be on our way with this one. Do your research on it. Not promoting it. Just sharing.